The release of granule constituents and, more profoundly, the de novo synthesis of lipid mediators are strongly regulated by the hematopoietic growth factors (HGF) interleukin-3 (IL-3), IL-5, and granulocyte-macrophage colony-stimulating factor (GM-CSF). In general, HGF do not induce the release of basophil mediators by themselves, but they augment the release reaction in response to FMLP or anti-IgE antibodies. In particular, HGF render basophils capable of producing sLT in response to agonists, such as the complementderived CSa, which are otherwise ineffective triggers for lipid mediator synthesis.24 Eosinophils and neutrophils are affected by HGF in a similar f a~h i o n .~,~ In neutrophils, however, GM-CSF was the only cytokine found so far to regulate lipid mediator formation.6 Thus, an important function of HGF lies in their capacity to prime mature inflammatory effector cells for lipid mediator synthesis in response to otherwise ineffective agonists, a property not shared by other cytokines, such as IL-1, -2, -4, -6, -7, -9, or transforming growth factor (3.4
fractionation studies indicate that NGF acts directly on human basophils without an involvement of other cell types, suggesting the presence of high-affinity NGF receptors on basophils. NGF by itself (up to 4 nmol/L of human NGF p) does not induce the release of inflammatory mediators directly. The effect of human NGF on basophil mediator release is similar to that of the hematopoietic growth factors interleukin-3, interleukin-5, and granulocyte-macrophage colony-stimulating factor. The present study further demonstrates that NGF acts as a pleiotropic cytokine at the interface between the nervous and the immune system, and that NGF may be involved in inflammatory processes and hypersensitivity reactions. 0 1992 by The American Society of Hematology.
low-affinity receptor have been characterized.I1J2 Initially, NGF has been described as a growth and differentiation factor for sympathetic and sensory neurons in vertebrates, but more recent studies indicated that this protein also has biologic activities outside the nervous system. In animal experiments, NGF induces degranulation of peritoneal mast cells and shape change of thrombocyte^.^^-'^ However, these biologic responses occurred only at very high NGF concentrations or in the presence of lyso-phospholipids. In the human system, two non-neurologic bioactivities of NGF have been reported recently: a proliferating and differentiating activity on B lymphocyte^,^*^^^ and a growth-promoting activity on myeloid progenitor cells.20-22 Thus, NGF has an HGF activity similarly to IL-3 or GM-CSF, although it seems that this NGF effect is T-cell dependent.21 It is unknown, however, whether NGF, analogous to HGF, also regulates the function of mature inflammatory effector cells.
In the present study, we examined the effect of purified natural mouse and recombinant human (rhu) NGF on basophil mediator release. Interestingly, rhuNGF, at picomolar concentrations, profoundly modulates basophil function within a few minutes of preincubation without inducing degranulation or leukotriene synthesis by itself. These results indicate an important role of NGF in allergic reactions and other inflammatory processes.
For most experiments, leukocytes were separated from erythrocytes by dextran-sedimentation and fractionated by Ficoll Hypaque density centrifugation (40% for 40 minutes at room temperature). The basophil-containing mononuclear cell layer was harvested, washed, and finally suspended at a density of 2.5 to 5 X 106 cells/mL in HACM-buffer (20 mmol/L HEPES, 125 mmol/L NaCI, 5 mmol/L KCI, 0.5 mmol/L glucose, 0.025% BSA, 1 mmol/L CaC12, and 1 mmol/L MgC12). These preparations contained 1% to 6% (mean, 2%) basophils as determined by stained cytocentrifuge slides. In some experiments, leukocytes were fractionated on discontinuous Percoll gradients (densities: 1.079, 1.070, and 1.062 containing the leukocytes) and centrifuged (500g,for 30 minutes at room temperature). The cell layers at the interface between the 1.070 and 1.062 gradient (4% to 10% basophils) and between the 1.079 and 1.070 gradient (20% to 50% basophils) were harvested and the latter was depleted of contaminating T cells, B cells, NK cells, and neutrophils using immunomagnetic beads (cell/beads ratio = 1:lO) coated with mouse anti-CD2 (60%), anti-CD19 (lo%), and anti-CDl6 monoclonal Ab (MoAb) (30%). The resulting basophil preparation (purity, 85% to 96%) was washed twice in HA-buffer and finally resuspended in HACM-buffer at a density of 1 to 2 x io5 cells/mL.
The p-form of rhuNGF, expressed in Chinese hamster ovary cells and purified to greater than 98%, was a generous gift from Genentech, Inc (South San Francisco, CA). The biologic activity of rhuNGF (molecular weight [MW] of the dimer, 25.6 Kd) was determined by neurite formation in PC12 cells (a rat pheochromocytoma cell line). A half-maximal activity in this assay was produced by 1.5 to 2 pmol/L ~~u N G F .~~ Murine NGF 7s complex (muNGF 7S, MW = 140 Kd), prepared from male mouse salivary glands and purified to 99% as assessed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), was from Boehringer Mannheim, Inc. MuNGF 7 s activity was determined by fiber outgrowth of chick embryo dorsal root ganglia and became maximal at 400 to 700 pmol/L. The lyophilized preparation was reconstituted according to the manufacturers instructions and further diluted in HA buffer containing 1 mg/mL BSA. Dr Y.A. Barde (Max-Planck-Institute of Psychiatry, Planegg-Martinsried, Germany) kindly provided us with COS-conditioned medium containing recombinant brain-derived neurotrophic factor (BDNF). Final dilutions of 1:lOO to 1:300 were maximally active in promoting the survival of spinal sensory neurons isolated from chick embry0s.2~ rhuIL-3 and rhuGM-CSF were from Sandoz (Basel, S~itzerland).*-~ Supernatants from Escherichia coli cultures expressing the human IL-5 protein were a generous gift from Dr C.J. Sanderson (National Institute for Medical Research, London, UK). These supernatants identically enhanced basophil mediator release (maximal effect at a dilution of 1:1,000) as the purified preparation4 The complement cleavage product C5a was purified from yeast-activated human serum as de~cribed.~ FMLP was from Fluka AG (Buchs, Switzerland); C18 platelet-activating factor (PAF) was from Novabiochem (Laufelfingen. Switzerland). AntiIgE LE27 MoAb was prepared as de~cribed.~
The experiments were performed in a thermostat-regulated (37°C) shaking water bath. In most experiments the cells were preincubated without or with cytokines (NGF, BDNF, IL-3, IL-5, GM-CSF) during 10 minutes and then stimulated with a triggering agent (C5a, anti-IgE Ab, FMLP) for 20 minutes, a time sufficient for maximal mediator release, as determined in earlier studies.3~~ The reaction was stopped by cooling the cell suspension on ice. Supernatants were obtained by centrifugation (4OOg for 10 minutes at 4°C) and divided into two parts: 0.4 mL were directly stored at -70°C for leukotriene measurement, 0.5 mL were mixed with 0.5 mL of HACM buffer and 1 mL of HCI04, centrifuged (60% for 15 minutes at 4"C), and these supernatants Cell stimuli.
Mediator release assay.
were also stored at -70°C for histamine measurement using an automated fluorometric m e t h~d .~ The sLT including LTC4/D4/E4 were measured by a fluid phase radioimmunoassay (RIA) based on competition between unlabeled LTC4 (standards or samples) and a fixed quantity of tritium-labeled LTC4 (tracer) for binding to a limited quantity of MoAb directed against sLT. The LTC4 tritium tracers, either [14,15-3H] LTC4 (specific activity, 39.3 Ci/mmol) or the higher labeled [14, 15, 19, 20 -3H]LTC4 (168.4 Ci/mmol), were from NEN research products (Boston, MA). Tracers were diluted in assay buffer (phosphate-buffered saline [PBS] 0.05 mol/L, pH 7.4, containing 10 mg/mL gelatine) to 1.77 and 0.38 pmol/mL, respectively. LTC4 standards (Amersham Corp, Arlington, IL) were diluted to 0.03 to 8 ng/mL in HACM buffer. The mouse MoAb against sLT (sLT-Ab) was kindly provided by Drs J. Mollenhauer and K. Brune (University of Erlangen-Nurnberg, Germany). This Ab had the same sensitivity for LTC4, LTD4, and LTE4, and showed no cross-reactivity to LTB4 and its metabolites, to prostaglandins Dz, E2, Fa, or to thromboxane Bz.25 The lyophylized unpurified sLT-Ab from cell culture supernatant was reconstituted in PBS/H20 1:l (1 mg of total protein/mL), and further diluted in assay buffer (1:lOO for the less sensitive assay, 1:300 for the high sensitive assay, determined to be optimal for each assay). One hundred microliters of supernatants or of standard LTC4 solutions + 100 pL of LTC4 tracer + 100 pL of sLT-MoAb solution + 100 pL of HACM buffer (400 pL in total per tube) were mixed. After overnight incubation at 4"C, 250 pL of charcoal suspension (assay buffer + 800 mg/mL charcoal, 160 mg/mL dextran T70, 1 mg/mL sodium azide) was added for 15 minutes to absorb unbound LTC4 tracer. Tubes were then centrifuged (2,000g for 15 minutes at 4"C), and 450 pL of the supernatants was transferred into scintillation vials. The amount of LTC4 tracer bound to the Ab was quantified in the p-counter and was inversely proportional to the concentration of unlabeled sLT. 'Zero standard' (without unlabeled LTC4) was 1,200 to 1,500 cpm (corresponding to 25% to 35% binding of the tracer to the antibody). 'Nonspecific binding' (zero standard without antibody addition) was less than 100 cpm. sLT from 12.5 to 800 pg/tube and from 3.125 to 400 pgitube, respectively, dependent on the assay used for measurement, could be detected (Fig 1) . Measurements were identical to those performed with a commercially available LTC4/D4/E4 RIA kit (Amersham Corp) following the manufacturers protocol, despite the fact that the polyclonal antiserum used in this assay recognizes LTD4 and LTE4 by only 64% as compared with LTC4. This is due to the negligible conversion of LTC4 to LTD4/E4 in mononuclear cells under incubation conditions used in this study, as we have shown previously by high performance liquid chromatography (HPLC).3 Nevertheless, the equal affinity of the sLT-Ab for all sLT is preferable because total sLT are measured, and results are not influenced by possible variations in LTC4 metabolism.
All experiments were performed at least in duplicate, and repeated three times or more. Histamine data are presented as mean of percent specific histamine release according to the formula 100 x to 800 pg/tube, and with the high specific activity tracer (A), the range was 3.125 t o 400 pg/tube of sLT. Nearly overlapping standard curves were obtained when unlabeled LTC4 was replaced by LTD4 or LTE4 (not shown).
RESULTS

Figure 2 shows that preincubation of basophils for 10
minutes with either rhuNGF p or muNGF 7s enhanced concentration-dependent histamine release as well as the generation of leukotrienes in response to anti-IgE Ab or FMLP. Apart from these enhancing effects, both NGF preparations also qualitatively changed the release profile in response to C5a, which by itself induced degranulation NGF rendered basophils capable of synthesizing lipid mediators in response to C5a, while histamine release was similarly enhanced as the response to FMLP or anti-IgE Ab. Figure 2 shows that this priming effect of rhuNGF p and muNGF 7s on human basophils occurred within a concentration range of 0.03 to 1 ng/mL and 10 to 100 ng/mL, reaching a plateau at 1 to 10 ng/mL and 100 to 1,000 ng/mL, respectively. Thus, basophils are influenced by rhuNGF p (ED50 = 4 pmol/L) and muNGF 7s (ED50 = 140 pmol/L) at concentrations similar to those required for stimulation of neuronal cells. Importantly, neither rhuNGF p nor muNGF 7s did induce any mediator release in basophils by themselves, up to concentrations of 100 ng/mL rhuNGF p and 1,000 ng/mL muNGF 7S, respectively (data not shown). By contrast, BDNF, a neurotrophic protein structurally related to NGF,24 failed to induce or modulate basophil mediator release at concentrations determined to be optimal for promoting survival of chick embryo sensory neurons (1:1,000 to 1:lOO dilutions).
There is a remarkable, well-known donor variability of basophil mediator release in response to anti-IgE Ab or FMLP, and to a lesser extent to C5a.4 Thus, in a large number of experiments, cells from different donors were preincubated in buffer control or with optimal concentrations of muNGF 7S, rhuNGF p, or rhuIL-3 within the same experiment. After 10 minutes, cells were triggered with maximally effective concentrations of C5a, FMLP, or antiIgE Ab (Fig 3) . IL-3 was included in these experiments, because we found in previous studies that, within the HGF capable of modifying basophil function, IL-3 is the most active ~ytokine.~ Figure 3 shows the variability of histamine and leukotriene release, respectively, from experiments performed with different donors, as well as mean values from the different stimulation protocols. Both muNGF 7s
and rhuNGF enhanced histamine release and sLT generation in response to C5a, anti-IgE Ab, and FMLP. Furthermore, in all experiments, NGF-primed basophils produced large amounts of sLT in response to C5a, while, with the exception of rare cases, no sLT were detected from cells stimulated with C5a alone. It should be noted that in all experiments mediator release in response to the three agonists was enhanced by NGF preincubation, when compared with the corresponding control value (paired t-test, all P < .001). The enhancement of mediator release due to For optimal concentrations of murine or human NGF did not differ significantly (all P > .05). However, mediator release, in particular in response to anti-IgE stimulation, was less pronounced after NGF preincubation as compared to the IL-3 effect (all P < .OS). In previous studies, we defined a set of cytokines (IL-3, GM-CSF, and IL-5) capable of strongly modulating basophil functions?-4 We therefore compared the effect of NGF with that of these HGF within the same experiments ( Table 1 ). The mediator release profile triggered by IgE-independent agonists such as C5a and FMLP was influenced by all four cytokines in a nearly identical fashion. However, particularly with regards to anti-IgE Ab-induced mediator release, NGF was clearly the least active priming agent.
The time interval between addition of NGF and second agonist (C5a, FMLP, anti-IgE Ab) was 10 minutes in all experiments described so far. This preincubation period has been determined to be optimal for basophil priming with HGF, such as IL-3, IL-5, or GM-CSF. 24 To evaluate whether this is transferable to basophil priming with NGF, the time interval between addition of NGF and C5a was varied from 10 seconds to 40 minutes. An optimal enhancement of C5a-induced mediator release occurred after a preincubation time of 10 to 15 minutes for both muNGF 7s
and rhuNGF (Fig 4A and B) . Even 40 minutes after NGF addition, basophils were still able to produce sLT in response to C5a, albeit slightly less efficiently than after the optimal time of preincubation. The major component of the priming process, in particular with regards to sLT synthesis, appeared within 2 to 10 minutes after NGF addition for both muNGF 7s and rhuNGF. However, rhuNGF, but not muNGF 7S, already enhanced C5a-induced histamine release significantly 10 seconds after NGF addition, as shown in more detail in Fig 4C . This early effect of rhuNGF was reproducible in three experiments from different donors. Histamine release was raised up to 20% to 30% of total cellular histamine content over the histamine release induced by C5a alone. The reason for the different effects of muNGF 7s and rhuNGF p at short preincubation times is unclear at present, but may be due to the necessity of dissociation of the NGF 7s complex to become active for basophil priming.* In three experiments, highly purified basophil preparations (85% to 96%) were used to determine the participation of other leukocyte types in the action of NGF on basophils. We also performed experiments with leukocyte preparations fractionated by Percoll gradients containing basophils of different densities and variable proportions of other leukocyte types. Figure 5A shows a representative experiment performed with a cell preparation of 96% basophil purity (contaminating cells were small lymphocytes). The data show that C5a-and anti-IgE Ab-induced mediator release was enhanced by rhuNGF. NGF-primed, but not unprimed, purified basophils release large amounts of sLT in response to C5a. The data were not different when, within the same experiment of the same cell fraction, depletion of T cells, B cells, NK cells, and neutrophils was 
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Control 3 9 2 1 0 1 9 2 3 5 2 1 3 6 2 1 11 2 2 rhuNGF 5 9 2 2 21 2 2 3 0 2 6 11 2 2 5 6 2 3 3 3 2 4 rhulL-3 6 4 2 2 3 0 2 2 4 6 2 9 2 5 t 6 6 2 2 4 3 9 2 6 rhulL- For personal use only. on November 11, 2017. by guest www.bloodjournal.org From 2666 omitted (Fig 5B) . The pattern of mediator release and the influence of NGF was identical in low density basophils derived from an upper cell layer (between 1.070 and 1.062 density gradients), mainly contaminated with lymphocytes. These cell preparations produced slightly larger amounts of leukotrienes, and in the supernatants of cells triggered by C5a alone some sLT was detected (Fig 5C) . We cannot decide at present whether functional differences exist within basophils of different densities, or whether the discretely larger amounts of sLT produced in the cell fractions of lower density are due to contaminating leukocytes, because we have not yet achieved a complete purification of hypodense basophils. However, the data clearly show that the modulating effect of NGF is independent of a contamination with other leukocyte types. The NGF effects on purified basophils. Basophils were purified t o 85% t o 96% purity by a combination of dextran sedimentation, discontinuous Percoll gradient centrifugation, and negative selection using immunomagnetic beads as described in Materials and Methods. One of three experiments performed with such cell preparations is shown. (A) 96% pure basophils (density interface, 1.079/ 1.070. depleted of contaminating cells); (B) 34% pure basophils (of the same Percoll density fraction as in [A], but without negative selection by antibody-coated beads, resulting in contamination with 22% neutrophils and 44% small lymphocytes); (C) 6% pure basophils (density interface: 1.070/ 1.062. contaminated with 89% lymphocytes and 5% monocytes). After a preincubation period of I O minutes without (E) or with 1 ng/mL of rhuNGF (B), all cell preparations were triggered with C5a (lo-* mol/L) or anti-lgE Ab (100 ng/mL) for 20 minutes. Histamine release (left panels) and leukotriene synthesis (right panels) data are presented as means of triplicates. The standard deviations within the experiment were always less than 15% of the mean.
DISCUSSION
The present study shows that human NGF at very low concentrations influences the function of one type of mature human effector cells, and shows a first biologic activity of pure rhuNGF p-chain outside the nervous system. This priming effect of NGF, which occurs when basophils have been preincubated for a few minutes in the presence of the neurotrophic cytokine, consists of an enhancement of histamine and sLT release induced by FMLP or anti-IgE Ab, or of a qualitative modification of the basophil response towards C5a, in which case NGF preincubation is required for lipid mediator synthesis.
Previous work with rat peritoneal mast cells showed that purified muNGF directly induces histamine release in a dose-dependent manner. However, degranulation occurred only at high concentrations ( 5 to 500 nmol/L of NGF), or in the presence of lysophospholipids.13-16 Furthermore, mu-NGF 2.5s induced a shape change in rabbit platelets at a concentration of 570 nmol/L.17 Such concentrations are For personal use only. on November 11, 2017. by guest www.bloodjournal.org From orders of magnitude above that required in ganglion or PC12 cell assays. In vivo, 4 to 400 pmol of muNGF 2.5s induced plasma extravasation in rat skin, which could be reduced by capsaicin pretreatment and by histamine antagonists, indicating an involvement of both a neurogenic (eg, via substance P) and a basophil/mast cell-dependent mechanism.27 By contrast, in the human system NGF is not a direct basophil agonist, because it induces no mediator release by itself, even at concentrations up to 100 ng/mL of rhuNGF, or up to 1 Fg/mL of muNGF 7s. Furthermore, in the presence of IL-3, in which case several otherwise inactive basophil triggers (C3a, IL-8, platelet-activating factor) efficiently induce histamine and sLT r e l e a~e ,~,~~ NGF is still ineffective (our unpublished results).
The effect of NGF on mature human basophils is remarkably similar to that of IL-3. In the mouse, IL-3 acts as a mast cell growth factor, while in human bone marrow cultures IL-3 induces proliferation and differentiation of myeloid progenitors into immature histamine-containing cells, which resemble basophils more than mast cells. 30 Furthermore, in contrast to basophils, human mucosal mast cells do not bear IL-3 receptors, and their function is not affected by IL-3.31,32 Interestingly, one of the earliest and most firmly established effects of NGF outside the nervous system in rats is its capacity to cause an increase in size and number of mast cells in several peripheral possibly through an autocrine involvement of mast cell product release.34 In the human system, however, NGF neither modulates nor induces granule release in human mucosal mast cells.32 Therefore, the biologic effects of NGF and IL-3 seem to be quite similar in the human as well as in the mouse system, except that the target cells, basophils, and mast cells, respectively, are different.
Among a large number of cytokines examined, only IL-3, IL-5, and GM-CSF were found to modulate the function of mature human basophils.24 Thus, NGF is the first basophil response modifier, which was not primarily described as a HGF. Of interest, Matsuda et a1 showed that muNGF also acts on human myeloid progenitor cells as a growth and differentiation factor in particular of the eosinophil and basophil/mast cell lineages?0,21 However, in contrast to the HGF properties of IL-3, GM-CSF, and IL-5, which affect the myeloid cells directly, this biologic activity of NGF appeared to be T-cell-dependent. Because of the similarity of biologic effects of these HGF and NGF on basophils as well as on myeloid progenitors, it is tempting to speculate that NGF stimulates the progenitor cells directly, but in synergism with a T cell product(s). Indeed, recent data showed that NGF promotes human granulopoiesis only in synergy with GM-CSF.22
The NGF effect on basophils is rapid and is independent of the degree of contamination by other leukocyte types, suggesting a direct effect of NGF on basophils through specific receptors. Sutter et aP5 described two classes of NGF receptors (NGFR), a high-affinity receptor (kd = 23 pmol/L) probably mediating nerve cell survival and neurite outgrowth, and a low-affinity receptor (kd = 1.7 nmol/L), which seems to be required but not sufficient for functional expression of high-affinity receptors.36 The low-affinity NGFR has been cloned in human, rat, and chicken, and binds NGF and even the related BDNF with equal affinity.12,37 Very recent studies indicate that the trk protooncogene either by itself or in combination with the low-affinity NGFR forms the high-affinity NGFR in neuronal ~e l l s .~~,~~ There is strong evidence that the biologic effect of NGF at picomolar concentrations on primary neurons of animal origin as well as on human basophils, as shown here, is mediated by a high-affinity NGFR.7,36 It is less clear whether the higher NGF concentrations required to affect human B cells and myeloid progenitor cells (ED50 = 10 to 50 ng/mL = 0.4 to 2 nmol/L)18-22 are due to the lack of high-affinity binding sites on these target cells or to a weaker bioactivity of muNGF on human cells. The low-affinity NGFR belongs to a family of structurally related membrane proteins including CD40, which has been regarded as a specific leukocyte marker of B cell^.^,^^ Recent studies, however, have shown that human basophils, but not mast cells, also express CD40.42 Interestingly, in humans, B lymphocytes and basophils both respond to NGF and express CD40, but whether this association is related to the biologic effects of NGF on these two cell types is unknown.
NGF belongs to an increasingly large family of neurotrophic proteins, which are strongly homologous in primary s t r u c t~r e .~,~~ Three family members have been identified, NGF, BDNF and neurotrophin 3 (NT3), with partially overlapping, partially distinct biologic activities on neuronal cells. It has been suggested that they could interact with a common binding protein, the low-affinity NGFR,43 possibly in association with accessory proteins creating high-affinity states specific for each neurotrophic f a~t o r .~~"~ Our own preliminary data indicate that BDNF does not affect basophil function at concentrations promoting survival of nodose neurons, further supporting the hypothesis of a high-affinity NGFR on basophils. Clearly, additional studies are needed to define the functional effects of other neurotrophic factors on basophils. muNGF 7s and rhuNGF fi prime basophils at a concentration range of 70 to 700 pmol/L and 1 to 40 pmol/L, respectively. These concentrations of both NGF preparations correspond well to those required to affect neuronal ~e l l s .~,~~ The extremely high biologic activity of rhuNGF p on basophils indicates that the bioactivity of muNGF 7s is due to the p-subunit. A definitive assessment of possible differences of bioactivity between mouse and human NGF p on human basophils would require a direct comparison of recombinant purified murine and human material under identical experimental conditions.
Our results extend and confirm the concept that NGF affects both the nervous and the immune system. However, the pathophysiologic significance of this interface between nervous and immune system, the site of NGF production, and the regulation of NGF during health and disease is still ~n c l e a r .~,~J~ In particular, informations on human tissue containing NGF are rare and controversial, in part due to difficulties and misinterpretations of NGF measurements by immunoassays or biologic assays7 Nevertheless, it is tempting to speculate that NGF is synthesized locally in For personal use only. on November 11, 2017. by guest www.bloodjournal.org From many tissues, possibly under the control of other cytokines,44 and may be involved in different pathologic conditions such as tumor growth, cell regeneration, tissue destruction, and wound healing, or in neurogenic or allergic inflammatory processes.
